YOUR
Search

    Life Sciences and Healthcare

    The life sciences and healthcare industries are cornerstones of European innovation and progress, and provide fertile ground for the emergence of new challenges driven by start-ups. ADVANT Altana has first-rate expertise in representing and assisting businesses active in these dynamic sectors.

    Our clients include some of the world's leading pharmaceutical, biotech, and nutraceuticals companies, as well as specialist healthcare start-ups, notably active in medical devices and equipment makers, public and private hospitals, clinics, and other healthcare service providers.

    We handle complex and international litigation, particularly in the field of product liability before all types of courts, and have recognised expertise in the field of group actions in health law.

    We also advise these companies on all regulatory issues (marketing authorisations, compliance, clinical trials, pharmacovigilance, health data protection) as well as on financing and contract drafting.

    We also assist our clients in all intellectual property matters, from the filing of patents and the exploitation of intellectual property rights (licensing agreements) to their defence before national or Community courts (including the Unified Patent Court/UPC). In addition, we have particular expertise in employee inventions. We also represent our clients in counterfeiting proceedings, particularly concerning counterfeit or falsified medicines. The same applies to trademark law specific to the health sector, both in terms of registration and legal action to ensure that trademarks are exploited.

    We operate in a variety of fields within the industry, including digital health and digital therapies, artificial intelligence and machine learning, healthcare provider and patient data profiling, cybersecurity, e-pharmacy, and telemedicine, among many others.

    The breadth of our expertise in the life sciences and healthcare sectors is an asset for our clients, particularly in the context of mergers and acquisitions, joint ventures, and spin-offs specific to this sector.